Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neharika Jain

DaVita Stock: Is DVA Outperforming the Healthcare Sector?

Denver, Colorado-based DaVita Inc. (DVA) provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. Valued at a market cap of almost $12.5 billion, the company also offers outpatient, hospital inpatient, and home-based hemodialysis services and operates clinical laboratories as well. 

Companies worth $10 billion or more are generally described as “large-cap” stocks, and DaVita fits right into that category. The company is a leading provider of dialysis services and is renowned for treating patients with chronic kidney failure and end-stage renal disease (ESRD). It is also known for offering a variety of healthcare services, including integrated treatment plans, personalized care teams, and health management services.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.